Enhanced Agent-Delivering Neural Probe Devices with Adaptive Coatings and Integrated Microfluidics

Improved neural probe devices with advanced coatings, microfluidics, and adaptive properties for enhanced agent delivery, reduced tissue damage, and real-time monitoring, offering a safer and more efficient treatment option for neurological disorders.

Known neural probes and devices have relatively thick profiles that can result in damage to the patient's brain tissue during use. The original patent's dissolvable agent delivery structure, while innovative, still has limitations in terms of controlled agent release and real-time monitoring. The new inventive concept addresses these limitations by introducing thin, flexible probe bodies with hydrophilic coatings, integrated microfluidic channels, and adaptive coatings that change properties in response to changes in brain tissue.

The enhanced neural probe devices feature a thin, flexible probe body with a hydrophilic coating designed to dissolve over a predetermined period, allowing for controlled agent delivery. The device also includes an integrated microfluidic channel connected to a reservoir containing the agent, enabling real-time agent delivery. Additionally, the device features an adaptive coating that changes its properties in response to changes in brain tissue, allowing for real-time monitoring and adaptation of agent delivery and neural stimulation. The device can be used to treat neurological disorders, such as delivering therapeutic agents through a porous surface and stimulating brain tissue using an electrode array.

The new inventive concept's novelty lies in the combination of thin, flexible probe bodies with hydrophilic coatings, integrated microfluidic channels, and adaptive coatings that change properties in response to changes in brain tissue. This unique combination enables controlled agent release, real-time monitoring, and adaptive neural stimulation, which is not present in the original patent or prior art.

Alternative embodiments of the inventive concept could include varying the material composition of the probe body, adapting the microfluidic channel design for different agent delivery rates, or incorporating additional sensors for real-time monitoring. Variations could also include using different types of coatings, such as bioresorbable matrices, or integrating the device with external systems for remote monitoring and control.

The enhanced neural probe devices have significant commercial potential in the treatment of neurological disorders, such as epilepsy, Parkinson's disease, and chronic pain. The devices could be marketed to hospitals, clinics, and research institutions, offering a safer and more efficient treatment option for patients. The market potential is substantial, with an estimated global market size of over $10 billion by 2025.